Applications of Magnetic Resonance Spectroscopy to Psychiatry

Abstract

The inaccessibility of the human brain to biochemical studies has historically challenged the ability of in vestigators to elucidate the pathophysiology of psychiatric syndromes. Magnetic resonance spectroscopy (MRS) now provides a noninvasive means of assessing neurochemistry in vivo. Since the first application of the technique to the study of the human brain, many new advances have been made. This new technology broadens the applications of the MRS. The major principles of the technique and compounds currently available for study are discussed in this article. A brief review of current and future applications of the technology to the field of psychiatry are discussed. NEUROSCIENTIST 5:192-196, 1999

Keywords

KEY WORDS Magnetic resonance spectroscopy Psychiatry NMR in vivo

Get full access to this article

View all access options for this article.

References

Cady EB , Costello AM , Dawson MJ , Delpy DT , Hope PL , Reynolds EO , et al. Noninvasive investigation of cerebral metaboilsm in newborn infants by phosphorus nuclear magnetic resonance spectroscopy. Lancet 1983;1:1059-62.

Cheng LL , Ma MJ , Becerra L. , Ptak T. , Tracey I. , Lackner A. , et al. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 1997;94:6408-13.

Tsai G. , Coyle JT N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995;46:531-40.

Hashimoto T. , Tayama M. , Miyazaki M. , Fujii E. , Harada M. , Miyoshi H. , et al. Developmental brain changes investigated with proton magnetic resonance spectroscopy. Dev Med Child Neurol 1995;37:398-405.

Haussinger D. , Laubenberger J. , vom Dahl S. , Ernst T. , Bayer S. , Langer M. , et al. Proton magnetic resonance spectroscopy studies on human brain myo-mositol in hypo-osmolanty and hepatic encephalopathy . Gastroenterology 1994;107:1475-80.

Yorek MA , Dunlap JA , Stefani MR , Davidson EP , Zhu X. , Eichberg J. Decreased myo-inositol uptake is associated with reduced bradykinin-stimulated phosphatidylinositol synthesis and diacylglycerol content in cultured neuroblastoma cells exposed to L-fucose. J Neurochem 1994 ;62:147-58.

Pettegrew JW , Keshavan MS , Mmshew NJ 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophr Bull 1993;19:35-53.

Shulman RG , Rothman DL , Blamire AM NMR studies of human bram function. Trends Biochem Sci 1994;19:522-6.

Sibson NR , Dhankhar A. , Mason GF , Behar KL , Rothman DL , Shulman RG In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proceedmgs of the Natioal Academy of Science 1997;94:2699-704.

10.

Gyulai L. , Wicklund SW , Greenstein R. , Bauer MS , Ciccione P. , Whybrow PC , Zimmerman J. , Kovachich G. , Alves W. Measurement of tissue lithium concentration by lithium magnetic resonance spectroscopy in patients with bipolar disorder. Biological Psychiatry 1991;29:1161-70.

11.

Passe TJ , Charles HC , Rajagopalan P. , Krishnan KR Nuclear magnetic resonance spectroscopy: a review of neuropsychiatric applications . Prog Neuropsychopharmacol Biol Psychiatry 1995;19: 541-63.

12.

Maier M. In vivo magnetic resonance spectroscopy. Applications in psychiatry . Br J Psychiatry 1995;167:299-306.

13.

Bertolino A. , Nawroz S. , Mattay VS , Barnett AS , Duyn JH , Moonen CT , et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996 ; 153:1554-63.

14.

Fukuzako H. , Fukuzako T. , Takeuchi K. , Ohbo Y. , Ueyama K. , Takigawa M. , et al. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:629-40.

15.

Deicken RF , Zhou L. , Schuff N. , Weiner MW Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr Res 1997;27:65-71.

16.

Renshaw PF , Yurgelun-Todd D.A. , Tohen M. , Gruber S. , Cohen BM Temporal lobe proton magnetic resonance spectroscopy of patients with first episode psychosis. Am J Psychiatry 1995 ;152: 444-6.

17.

Buckley PF , Moore C. , Long H. , Larkin C. , Thompson P. , Mulvany F. , et al. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 1994;36:792-800.

18.

Brooks WM , Hodde-Vargas J. , Vargas LA , Yeo RA , Ford CC , Hendren RL Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study. Biol Psychiatry 1998;43:263-9.

19.

Bertolino A. , Esposito G. , Callicott JH , Mattay VS , Van Horn JD , Frank JA , et al. Neurophysiological correlates of 1H-magnetic resonance spectroscopic imaging. Biol Psychiatry 1998;43:63S.

20.

Stanley JA , Williamson PC , Drost DJ , Carr TJ , Rylett RJ , Momson-Stewart S. , et al. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study. Schizophr Res 1994 ;13:209-15.

21.

Fukuzako H. , Takeuchi K. , Ueyama K. , Fukuzako T. , Hokazono Y. , Hirakawa K. , et al. 31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neurolepticresistant marked positive symptoms . Eur Arch Psychiatry Clin Neurosci 1994;244:236-40.

22.

Deicken RF , Calabrese G. , Merrin EL , Vinogradov S. , Fein G. , Weiner MW , et al. 31Phosphorus magnetic resonance spectroscopy of the frontal and panetal lobes in chronic schizophrenia. Biol Psychiatry 1994;36:503-10.

23.

Stanley JA , Williamson PC , Drost DJ , Carr TJ , Rylett RJ , Malla A. , et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy [published erratum appears in Arch Gen Psychiatry 1995;52:799]. Arch Gen Psychiatry 1995;52:399-406.

24.

Keshavan MS , Pettegrew JW , Panchalingham KS , Kaplan D. , Bozik E. Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia . Arch Gen Psychiatry 1991;48:1112-3.

25.

George TP , Spence MW Alterations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy [letter]. Arch Gen Psychiatry 1996;53:1065-6.

26.

Bartha R. , Williamson PC , Drost DJ , Malla A. , Carr TJ , Cortese L. , et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1997;54:959-65.

27.

Klunk We Pk , Moossy J. , McClure RJ , Pettegrew JW NAA and other ammo acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study. Neurology 1992;42:1578-85.

28.

Shonk TK , Moats RA , Gifford P. , Michaelis T. , Mandigo JC , Izumi J. , et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy . Radiology 1995;195:65-72.

29.

Shiino A. , Matsuda M. , Morikawa S. , Inubushi T. , Akiguchi I. , Handa J. Proton magnetic resonance spectroscopy with dementia. Surg Neurol 1993;39:143-7.

30.

Shonk T. , Ross BD Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magn Reson Med 1995;33:858-61.

31.

Deicken RF , Weiner MW , Fein G. Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord 1995;33:195-9.

32.

Stoll AL , Sachs GS , Cohen BM , Lafer B. , Christensen JD , Renshaw PF Choline m the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry 1996;40:382-8.

33.

Hamakawa H. , Kato T. , Murashita J. , Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 1998; 248:53-8.

34.

Renshaw PF , Lafer B. , Babb SM , Fava M. , Stoll AL , Christensen JD , et al. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1997;41:837-43.

35.

Sanacora G. , Rothman DL , Behar KL , Krystal JH Decreased cortical GABA in depression. 36th Annual Meeting of the Amencan College of Neuropsychopharmacology; 1997 p. 125; Kamuela, Hawaii, 1997 Dec 8-12

36.

Meyerhoff DJ , MacKay S. , Sappey-Mannier D. , Deicken R. , Calabrese G. , Dillon WP , et al. Effects of chronic alcohol abuse and HIV infection on brain phosphorous metabolites . Alcohol Clin Exp Res 1995;19:685-92.

37.

Martin PR , Gibbs SJ , Minnerrichter AA , Riddle WR , Welch LW , Willcott MR Brain proton magnetic resonance spectroscopy studies in recently detoxified alcoholics. Alcohol Clin Exp Res 1995; 19:685-92.

38.

Behar K. , Hooten M. , Petersen K. , Shulman RG , Petroff Oac , Namanworth S. , White J. , Petrakis I. , Charney DS , Rothman DL , Krystal JH Reduced cortical GABA levels on alcoholics assessed by magnetic resonance spectroscopy. Alcohol Clin Exp Res 1996; 20:181.

39.

Dager SR , Marro KI , Richards TL , Metzger GD Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. Am J Psychiatry 1994 ;151:57-63.

40.

Goddard AW , Rothman DL , Behar KL , Banks GM , Charney DS , Krystal JH Cortical GABA levels in panic disorder. 36th Annual Meeting of the Amencan College of Neuropsychopharmacology; 1997 Dec 8-12; Kamuela, Hawaii . p. 144.